Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31,249,203
-
Total 13F shares
-
2,385,295
-
Share change
-
+2,383,797
-
Total reported value
-
$23,109,542
-
Put/Call ratio
-
329%
-
Price per share
-
$9.69
-
Number of holders
-
36
-
Value change
-
+$23,097,542
-
Number of buys
-
35
Institutional Holders of Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) as of Q3 2020
As of 30 Sep 2020,
Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,385,295 shares.
The largest 10 holders included
Consonance Capital Management LP, VANGUARD GROUP INC, BlackRock Inc., Sio Capital Management, LLC, J. Goldman & Co LP, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, Rubric Capital Management LP, DEUTSCHE BANK AG\, and Bank of New York Mellon Corp.
This page lists
36
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.